Research strategy for RNOHIOMS - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Research strategy for RNOHIOMS

Description:

Research strategy for RNOH-IOMS. David Marsh. Professor of Clinical Orthopaedics. Institute of Orthopaedics and Musculoskeletal Science, University College London ... – PowerPoint PPT presentation

Number of Views:68
Avg rating:3.0/5.0
Slides: 25
Provided by: profdav
Category:

less

Transcript and Presenter's Notes

Title: Research strategy for RNOHIOMS


1
Research strategy for RNOH-IOMS
Trust Board April 2008
  • David Marsh
  • Professor of Clinical Orthopaedics
  • Institute of Orthopaedics and Musculoskeletal
    Science, University College London
  • Royal National Orthopaedic HospitalStanmore, UK

2
A joint IOMS-RNOH academic strategy is an
essential part of the Outline Business Case
  • One of three stipulations in the letter from the
    SHA inviting submissionset out a clear
    commitment to support the work of the university
    and its partners in achieving AHSC status and
    strengthening the Orthopaedic Institute

3
Academic Health Science Centre
  • Joint Academic Plan
  • integration of UG and PG education
  • RD management into IOMS
  • Research strategy

CLINICAL
EXCELLENCE,INTEGRATION
EDUCATION
RESEARCH
How are we going to fund this?
4
Research Strategy
  • Focused on musculoskeletal system but full
    spectrum

Health services research
Basic science
Clinical trials
Translational Experimental
  • Five themes, building on track record and patient
    needs
  • Innovative implant design
  • Cell therapy and tissue engineering
  • Disability and improvement of quality of life
  • Building the musculoskeletal evidence base
  • Sarcoma medicine

5
Tapping in to UCL
Musculoskeletal Consortium
  • Five centres in IOMS
  • Bioengineering
  • Tissue engineering
  • Clinical academic
  • Rehabilitation
  • Pathology
  • Innovative implant design
  • Cell therapy and tissue engineering
  • Disability and improvement of quality of life
  • Building the musculoskeletal evidence base
  • Sarcoma medicine

Engineering
Centre for Ageing
Cancer Institute
6
Funding
UKCC
EPSRCBBSRC
MRC
NIHR
Basic science
Translational Experimental
Clinical trials
Health services research
ARC, charities
7
National Institute for Health Research - the new
research environment
  • Concentration of funded clinical research in
    fewer, larger centres
  • Large research teams
  • Epidemiology, health economics vital
  • Many Trusts giving up and outsourcing research
    management
  • Competition with all other specialities - fierce
  • Priorities in cancer, neuro, endocrine, mental,
    children
  • Role of rheumatology
  • Research governance demands tighter

Transform or fade out
8
NIHR funding streams
  • Comprehensive biomedical research
    centresSpecialist BMRCsBiomedical Research
    Units
  • Musculoskeletal in Oxford, Sheffield, Leeds
  • Local Comprehensive Research Networks
  • HTA, RfPB, NEAT, RISC
  • Applied Research Programme Grants
  • Technology Support Board

9
MRC Translational Research Call
  • 241m extra, most on translational research
  • Bottlenecks
  • Pan-UCL bid going in
  • MRC Centre for Cell and Gene Therapy
  • Stanmore hopefully to contribute cell therapy in
    the musculoskeletal system

10
Cell-based therapy
  • Clinical trials in ACI
  • Preclinical work on bone, collagen
  • Regenerative Medical Systems - UK
  • Translational teams
  • Bone
  • Tendon
  • Cartilage

11
Stanmore Clinical Research Facility
  • At present a joint venture between RNOHT and UCLB
    may change
  • Goal is to facilitate rapid study design,
    costing, governance and conduct
  • Both investigator-led and commercial
  • All must be fully funded
  • Building a clinical research network is crucial
  • eg fragility fractures and drugs that enhance
    fracture healing

12
Research pipeline in cell-based therapy
Health services research
Basic science
Clinical trials
Translational Experimental
What phenotype of cultured cells produces the
best clinical response?
Is it cost-effective to culture-expand cells
rather than use bone marrow?
Can we design new way ways of efficiently
expanding stem cells?
IOMS
RMS-UK
SCRF
13
Integrated Academic Training Programme
  • Four Academic Clinical Fellows
  • Two Clinical Lecturers

14
Academic Research Board
15
Research Support Staff
  • Academic Clinical Centre of IOMS
  • MRC Clinical Trial Unit support
  • Chair of Musculoskeletal Epidemiology
  • Alex MacGregor starting Sep 08
  • RD Director and Manager (Joseph Datukasi)
  • Nerina Head of Academic Business Development
  • SCRF staff
  • IT systems for research support Simon Grange

16
Research Governance
  • MHRA inspection
  • Duties of Principal Investigators
  • Duties of RNOH as a sponsor
  • Our IT solutions

17
MHRA Inspection
18
MHRA Inspection
19
Support we can offer
  • Training
  • Executive GCP training
  • Research Pack
  • Best methodological practice in musculoskeletal
    research
  • Governance
  • Integration locally with Risk assessment
  • Integration with Local Comprehensive Research
    Network
  • Research
  • Finding Research Partnerships
  • Developing hypotheses and designing studies
  • Finding funding sources

20
Research Governance
21
Clinical Trials Support
  • Being tested by our iBSc MSc students

22
Electronic Patient Record
23
05
06
07
08
09
10
11
12
My tenure
Team building
Joint academic strategy capacity building
Multidisciplinary MSc
Integrated Academic Training Programme
24
05
06
07
08
09
10
11
12
Expenditure
NHS RD
UCL
Grant targetoverheads, contributions to salary,
SCRF profit
MRC stem cells in nonunion 300k
Pfizer fracture accelerating drug 500k
TSB grant 500k
NIHR Applied Research Programme 2m
Write a Comment
User Comments (0)
About PowerShow.com